286 related articles for article (PubMed ID: 38730426)
1. Prognostic value of metabolic dysfunction-associated steatotic liver disease over coronary computed tomography angiography findings: comparison with no-alcoholic fatty liver disease.
Nishihara T; Miyoshi T; Nakashima M; Miki T; Toda H; Yoshida M; Ichikawa K; Osawa K; Yuasa S
Cardiovasc Diabetol; 2024 May; 23(1):167. PubMed ID: 38730426
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Non-alcoholic Fatty Liver Disease and RCA Pericoronary Adipose Tissue CT Attenuation in Patients with Acute Chest Pain.
Yang W; Wen D; Li S; Zhao H; Xu J; Liu J; Chang Y; Xu J; Zheng M
Acad Radiol; 2024 May; 31(5):1773-1783. PubMed ID: 38160090
[TBL] [Abstract][Full Text] [Related]
3. Association between severity of nonalcoholic fatty liver disease and major adverse cardiovascular events in patients assessed by coronary computed tomography angiography.
Shi R; Li X; Sun K; Liu F; Kang B; Wang Y; Wang Y; Zhu B; Zhao X; Liu Z; Wang X
BMC Cardiovasc Disord; 2024 May; 24(1):267. PubMed ID: 38773388
[TBL] [Abstract][Full Text] [Related]
4. Incremental prognostic value of non-alcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease.
Ichikawa K; Miyoshi T; Osawa K; Miki T; Toda H; Ejiri K; Yoshida M; Nakamura K; Morita H; Ito H
Eur J Prev Cardiol; 2022 Feb; 28(18):2059-2066. PubMed ID: 34279027
[TBL] [Abstract][Full Text] [Related]
5. Plaque progression at coronary CT angiography links non-alcoholic fatty liver disease and cardiovascular events: a prospective single-center study.
Yu MM; Tang XL; Zhao X; Chen YY; Xu ZH; Wang QB; Zeng MS
Eur Radiol; 2022 Dec; 32(12):8111-8121. PubMed ID: 35727319
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Coronary CT Angiography for Predicting Poor Cardiac Outcome in Stroke Patients without Known Cardiac Disease or Chest Pain: The Assessment of Coronary Artery Disease in Stroke Patients Study.
Yoon SH; Kim E; Jeon Y; Yi SY; Bae HJ; Jang IK; Lee JM; Yoo SM; White CS; Chun EJ
Korean J Radiol; 2020 Sep; 21(9):1055-1064. PubMed ID: 32691541
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study.
Ichikawa K; Miyoshi T; Osawa K; Miki T; Toda H; Ejiri K; Yoshida M; Nanba Y; Yoshida M; Nakamura K; Morita H; Ito H
Cardiovasc Diabetol; 2021 Jan; 20(1):8. PubMed ID: 33413363
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Dysfunction Associated Liver Disease in Patients Undergoing Coronary Computed Tomography Angiography.
Orzan RI; Gligor RI; Agoston R; Cionca C; Zlibut A; Pais R; Seicean A; Agoston-Coldea L
J Cardiovasc Dev Dis; 2024 Feb; 11(3):. PubMed ID: 38535100
[TBL] [Abstract][Full Text] [Related]
9. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.
Lee SB; Park GM; Lee JY; Lee BU; Park JH; Kim BG; Jung SW; Jeong ID; Bang SJ; Shin JW; Park NH; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee HC
J Hepatol; 2018 May; 68(5):1018-1024. PubMed ID: 29274406
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease is associated with myocardial ischemia by CT myocardial perfusion imaging, independent of clinical and coronary CT angiography characteristics.
Ren Z; Wen D; Xue R; Li S; Wang J; Li J; Wang Q; Zheng M
Eur Radiol; 2023 Jun; 33(6):3857-3866. PubMed ID: 36571601
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study.
Chan K; Wahome E; Tsiachristas A; Antonopoulos AS; Patel P; Lyasheva M; Kingham L; West H; Oikonomou EK; Volpe L; Mavrogiannis MC; Nicol E; Mittal TK; Halborg T; Kotronias RA; Adlam D; Modi B; Rodrigues J; Screaton N; Kardos A; Greenwood JP; Sabharwal N; De Maria GL; Munir S; McAlindon E; Sohan Y; Tomlins P; Siddique M; Kelion A; Shirodaria C; Pugliese F; Petersen SE; Blankstein R; Desai M; Gersh BJ; Achenbach S; Libby P; Neubauer S; Channon KM; Deanfield J; Antoniades C;
Lancet; 2024 Jun; 403(10444):2606-2618. PubMed ID: 38823406
[TBL] [Abstract][Full Text] [Related]
12. Age-related risk of major adverse cardiac event risk and coronary artery disease extent and severity by coronary CT angiography: results from 15 187 patients from the International Multisite CONFIRM Study.
Nakazato R; Arsanjani R; Achenbach S; Gransar H; Cheng VY; Dunning A; Lin FY; Al-Mallah M; Budoff MJ; Callister TQ; Chang HJ; Cademartiri F; Chinnaiyan K; Chow BJ; Delago A; Hadamitzky M; Hausleiter J; Kaufmann P; Raff G; Shaw LJ; Villines T; Cury RC; Feuchtner G; Kim YJ; Leipsic J; Berman DS; Min JK
Eur Heart J Cardiovasc Imaging; 2014 May; 15(5):586-94. PubMed ID: 24714312
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pericoronary adipose tissue attenuation in patients with non-alcoholic fatty liver disease with suspected coronary artery disease.
Ichikawa K; Miyoshi T; Nakashima M; Nishihara T; Osawa K; Miki T; Toda H; Yoshida M; Ito H
Heart Vessels; 2022 Dec; 37(12):1977-1984. PubMed ID: 35672527
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome, fatty liver, and artificial intelligence-based epicardial adipose tissue measures predict long-term risk of cardiac events: a prospective study.
Lin A; Wong ND; Razipour A; McElhinney PA; Commandeur F; Cadet SJ; Gransar H; Chen X; Cantu S; Miller RJH; Nerlekar N; Wong DTL; Slomka PJ; Rozanski A; Tamarappoo BK; Berman DS; Dey D
Cardiovasc Diabetol; 2021 Jan; 20(1):27. PubMed ID: 33514365
[TBL] [Abstract][Full Text] [Related]
15. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.
Younossi ZM; Paik JM; Stepanova M; Ong J; Alqahtani S; Henry L
J Hepatol; 2024 May; 80(5):694-701. PubMed ID: 38286339
[TBL] [Abstract][Full Text] [Related]
16. Coronary artery volume index: a novel CCTA-derived predictor for cardiovascular events.
Benetos G; Buechel RR; Gonçalves M; Benz DC; von Felten E; Rampidis GP; Clerc OF; Messerli M; Giannopoulos AA; Gebhard C; Fuchs TA; Pazhenkottil AP; Kaufmann PA; Gräni C
Int J Cardiovasc Imaging; 2020 Apr; 36(4):713-722. PubMed ID: 31894527
[TBL] [Abstract][Full Text] [Related]
17. Coronary atherosclerosis scoring with semiquantitative CCTA risk scores for prediction of major adverse cardiac events: Propensity score-based analysis of diabetic and non-diabetic patients.
van den Hoogen IJ; van Rosendael AR; Lin FY; Lu Y; Dimitriu-Leen AC; Smit JM; Scholte AJHA; Achenbach S; Al-Mallah MH; Andreini D; Berman DS; Budoff MJ; Cademartiri F; Callister TQ; Chang HJ; Chinnaiyan K; Chow BJW; Cury RC; DeLago A; Feuchtner G; Hadamitzky M; Hausleiter J; Kaufmann PA; Kim YJ; Leipsic JA; Maffei E; Marques H; de Araújo Gonçalves P; Pontone G; Raff GL; Rubinshtein R; Villines TC; Gransar H; Jones EC; Peña JM; Shaw LJ; Min JK; Bax JJ
J Cardiovasc Comput Tomogr; 2020; 14(3):251-257. PubMed ID: 31836415
[TBL] [Abstract][Full Text] [Related]
18. Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease.
Wang SW; Hsieh TH; Cheng YM; Wang CC; Kao JH
Hepatol Int; 2024 Jun; 18(3):943-951. PubMed ID: 38227142
[TBL] [Abstract][Full Text] [Related]
19. The association of the steatosis severity in fatty liver disease with coronary plaque pattern in general population.
Hsu PF; Wang YW; Lin CC; Wang YJ; Ding YZ; Liou TL; Huang SS; Lu TM; Chan WL; Lin SJ; Leu HB
Liver Int; 2021 Jan; 41(1):81-90. PubMed ID: 33373113
[TBL] [Abstract][Full Text] [Related]
20. [Value of fractional flow reserve derived from coronary computed tomographic angiography and plaque quantitative analysis in predicting adverse outcomes of non-obstructive coronary heart disease].
Liu J; Wu Y; Huang H; Wang P; Wu Q; Qiao H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jun; 35(6):615-619. PubMed ID: 37366128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
